See what whales do with MRNA


A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna.

Looking at the options history for Moderna MRNA, we detected 40 strange trades.

Considering the specifics of each trade, it is correct to say that 42% of investors opened trades with bullish expectations and 57% with bearish.

Of the total trades spotted, 17 are puts, for a total amount of $869,654 and 23 are calls, for a total amount of $1,405,294.

What is the price target?

Taking into account the volume and open interest on these contracts, it appears that whales have been targeting a price range of $65.0 to $480.0 for Moderna for the past 3 months.

Volume & Open Interest Development

Looking at volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest rates for Moderna’s options at a particular strike price.

Below, we can observe the evolution of volume and open interest in calls and puts, respectively, for all of Moderna’s whale business within a strike price range of $65.0 to $480.0 over the past 30 days.

Moderna option volume and interest outstanding over the past 30 days

Options Call schedule

Biggest options spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trading Price Open Interest Volume MRNA CALL SWEEP NEUTRAL 09/16/22 $90.00 $168.2K 0 91 MRNA PUT TRADE BEARISH 04/14/22 $300.00 $167.0K 1.4K 10 MRNA CALL TRADE BEARISH 01/20/23 $140.00 $144.2K 732 183 MRNA CALL SWEEP BULLISH 9/16/22 $80.00 $143.1K 24 23 MRNA CALL TRADE NEUTRAL 01/20/23 $150.00 $119.5K 892 71

Where is Moderna now?

With a volume of 6,099,309, the price of MRNA is up 9.68% to $141.8. RSI indicators indicate that the underlying stock is currently neutral between overbought and oversold. The next profit is expected to be released in 57 days.

What the experts are saying about Moderna:

Morgan Stanley has decided to maintain their Equal-Weight rating on Moderna, which currently stands at a price target of $205. Deutsche Bank has decided to maintain their Hold rating on Moderna, which currently stands at a price target of $155. SVB Leerink has decided to maintain the Underperform rating on Moderna, which currently has a target price of $81.

Options are a riskier asset compared to just trading the stock, but they have a higher earning potential. Serious options traders manage this risk by informing themselves on a daily basis, scaling in and out of trades, tracking more than one indicator and closely monitoring the markets.

If you are already an options trader or want to get started, head over to Benzinga Pro. Benzinga Pro gives you up-to-date news and analysis to power your investment and trading strategy.

This post See what whales do with MRNA was original published at “”


Please enter your comment!
Please enter your name here